For many years, Davis Polk has been one of the most active advisers to the largest and most innovative companies across the pharmaceuticals, biotechnology, benefits management, medical devices and equipment, diagnostics, genetics and related sectors.
We are regularly called upon to advise on the most significant transactions that take place within the industry. Through our broad transactional experience, we understand the complex issues – including FDA, regulatory and intellectual property issues – that these companies face in financings, licensings, acquisitions and strategic partnership. In addition, our litigators regularly advise some of the industry's largest companies on major antitrust investigations and challenges, mass tort cases and consumer actions, patent litigation and other commercial disputes.
We have advised on some of the industry's most high-profile transactions. View our recent experience in: